Roubaix Capital LLC Buys 189,343 Shares of Stevanato Group S.p.A. $STVN

Roubaix Capital LLC raised its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 96.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 385,316 shares of the company’s stock after purchasing an additional 189,343 shares during the period. Stevanato Group accounts for 2.5% of Roubaix Capital LLC’s portfolio, making the stock its 19th largest holding. Roubaix Capital LLC’s holdings in Stevanato Group were worth $5,298,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Conestoga Capital Advisors LLC lifted its stake in shares of Stevanato Group by 7.6% in the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock worth $116,762,000 after buying an additional 602,050 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in Stevanato Group in the 4th quarter valued at $9,269,000. Norges Bank acquired a new position in Stevanato Group in the 4th quarter valued at $8,185,000. Credit Agricole S A bought a new position in Stevanato Group in the 3rd quarter worth $9,785,000. Finally, T. Rowe Price Investment Management Inc. lifted its position in Stevanato Group by 10.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after acquiring an additional 368,792 shares during the last quarter.

Stevanato Group Stock Performance

Shares of NYSE STVN opened at €19.21 on Friday. The business has a fifty day simple moving average of €18.24 and a 200 day simple moving average of €17.08. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $5.82 billion, a price-to-earnings ratio of 32.57, a PEG ratio of 1.77 and a beta of 0.78. Stevanato Group S.p.A. has a one year low of €12.89 and a one year high of €28.00.

Stevanato Group (NYSE:STVN) last issued its earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The firm had revenue of €273.57 million during the quarter. During the same period in the prior year, the business posted $0.10 earnings per share. Stevanato Group’s revenue for the quarter was up 6.6% compared to the same quarter last year. Sell-side analysts expect that Stevanato Group S.p.A. will post 0.68 EPS for the current year.

Analysts Set New Price Targets

STVN has been the subject of a number of recent analyst reports. Wolfe Research started coverage on shares of Stevanato Group in a report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price target for the company. Weiss Ratings upgraded Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Finally, TD Cowen raised Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy”.

Insider Buying and Selling at Stevanato Group

In other news, Director William J. Federici sold 1,493 shares of Stevanato Group stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the sale, the director directly owned 26,991 shares in the company, valued at approximately €461,276.19. The trade was a 5.24% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Madhavan Balachandran sold 1,493 shares of Stevanato Group stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the sale, the director owned 69,458 shares in the company, valued at approximately €1,187,037.22. This trade represents a 2.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 5,972 shares of company stock worth $102,061. Corporate insiders own 0.70% of the company’s stock.

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.